New York, New York, United States The main office of represented VC is situated in the New York. The company was established in North America in United States.
The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. When the investment is from Longevity Vision Fund the average startup value is 100-500 millions dollars. The fund is generally included in 2-6 deals every year.
We can highlight the next thriving fund investment areas, such as Medical, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight LyGenesis. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Longevity Vision Fund, startups are often financed by Founders Fund, Data Collective DCVC, Bold Capital Partners. The meaningful sponsors for the fund in investment in the same round are Bold Capital Partners, Wanxiang Healthcare Investments, Verily.
Related Funds
| Fund Name | Location |
| 2invest | Beau Vallon, Mahé, Seychelles |
| Fondaco SGR | Italy, Piemont, Turin |
| HDS Capital | New York, New York, United States |
| Liepin | Beijing, Beijing, China |
| Milk Capital | - |
| Procter & Gamble Company | Cincinnati, Ohio, United States |
| Weizhuo Touzi | China, Guangdong, Shenzhen |
| WertInvest | Austria, Vienna |
| Yilai Investment Management | - |
| Zhongqi Touzi | China, Ürümqi, Xinjiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Senda Biosciences | $123M | 16 Aug 2022 | Cambridge, Massachusetts, United States | ||
Tessera Therapeutics | $300M | 19 Apr 2022 | Cambridge, Massachusetts, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
Laronde | $440M | 30 Aug 2021 | Cambridge, Massachusetts, United States | ||
Exo | $220M | 29 Jul 2021 | Redwood City, California, United States | ||
Senda Biosciences | $98M | 10 Jun 2021 | Cambridge, Massachusetts, United States | ||
Tessera Therapeutics | $230M | 12 Jan 2021 | Cambridge, Massachusetts, United States | ||
Valo Health | $190M | 11 Jan 2021 | Boston, Massachusetts, United States | ||
Eko | $65M | 09 Nov 2020 | Oakland, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Senda Biosciences | $123M | 16 Aug 2022 | Cambridge, Massachusetts, United States | ||
Tessera Therapeutics | $300M | 19 Apr 2022 | Cambridge, Massachusetts, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
Laronde | $440M | 30 Aug 2021 | Cambridge, Massachusetts, United States | ||
Exo | $220M | 29 Jul 2021 | Redwood City, California, United States | ||
Senda Biosciences | $98M | 10 Jun 2021 | Cambridge, Massachusetts, United States | ||
Tessera Therapeutics | $230M | 12 Jan 2021 | Cambridge, Massachusetts, United States | ||
Valo Health | $190M | 11 Jan 2021 | Boston, Massachusetts, United States | ||
Eko | $65M | 09 Nov 2020 | Oakland, California, United States |
